Memorial Sloan Kettering

Department of Public Affairs

Recent Blog Posts

Pictured: Paul Chapman
Finding
Friday, December 7, 2012

Memorial Sloan Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma.

Feature
Monday, December 3, 2012

Memorial Sloan Kettering physicians and nurses take their knowledge and expertise overseas.

Pictured: Carol Brown
Video
Wednesday, November 28, 2012

Gynecologic cancer surgeon Dr. Brown discusses how doctors and nurses collaborate to care for patients, from diagnosis through lifelong follow-up.

Pictured: Jatin Shah
Video
Monday, November 12, 2012

Dr. Shah, Chief of the Head and Neck Service, discusses how Memorial Sloan Kettering’s world-renowned head and neck surgeons partner with patients to select the most appropriate treatment plan.

Pictured: James Huang
Video
Wednesday, October 31, 2012

Dr. Huang discusses how minimally invasive, video-assisted, and robotic surgical techniques improve the treatment of patients with lung, esophageal, and thyroid cancers.

Pictured: Cycle for Survival
Event
Thursday, October 25, 2012

Organizers expect this year to be the most successful yet for this national indoor team cycling event, which raises funds for rare cancer research at Memorial Sloan Kettering.

Pictured: Nadeem Abu-Rustum
Video
Monday, October 22, 2012

Dr. Abu-Rustum, Director of Minimally Invasive Surgery for the Gynecology Service, discusses how the gynecologic cancer care team treats each woman with an individualized approach.

Pictured: Lisa DeAngelis
Honor
Friday, October 19, 2012

Dr. DeAngelis has been elected to the Institute of Medicine (IOM), considered one of the highest honors in the field of health and medicine.

Pictured: Carol Lee
Q&A
Wednesday, October 10, 2012

During Breast Cancer Awareness Month, Dr. Lee discusses mammography, breast MRI, and breast ultrasound.

Pictured: Tunneling Nanotubes
Snapshot
Wednesday, September 19, 2012

Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.

Pictured: 2011 Annual Report
Announcement
Thursday, September 13, 2012

Our Annual Report features ten of the year’s most important research and clinical advances, the result of work led by physician-scientists and basic-science investigators.

Pictured: Architectural Rendering
Announcement
Monday, September 10, 2012

Memorial Sloan Kettering has announced its intention to build a new, state-of-the-art outpatient cancer treatment facility on Manhattan’s Upper East Side.

Pictured: José Baselga
Announcement
Wednesday, September 5, 2012

Internationally recognized physician-scientist José Baselga has been named Physician-in-Chief of Memorial Hospital. He joins Memorial Sloan Kettering from Massachusetts General Hospital.

Pictured: Charles Sawyers & Howard Scher
Announcement
Friday, August 31, 2012

Enzalutamide, a targeted therapy co-invented by a Memorial Sloan Kettering investigator, has received FDA approval for the treatment of men with metastatic prostate cancer.

Pictured: John Healey
Announcement
Wednesday, August 29, 2012

We recently launched our first-ever television advertising campaign, which offers a sense of the passion and compassion that defines how we care for people with cancer.